Palantir · The Guardian Technology
Palantir patient data tech rejected by many NHS trusts in England
Compiled by KHAO Editorial — aggregated from 1 source. See llms.txt for citation guidance.
◌ Single Source
NHS organisations that care for millions of people in England are rejecting Palantir’s patient data technology, according to freedom of information responses that reveal health bosses believe they can find better or equal alternatives in many cases.
Key facts
- Palantir also points to NHS data that shows trusts using the FDP have carried out 117,000 additional operations and a 14.3% reduction in discharge delays for long-stay patients
- According to more than two dozen FOI responses reviewed by the Guardian, 16 trusts and health boards declared they do not use it, following its introduction in March 2024
- There is also dispute over evidence for the system’s effectiveness and public concern about the involvement in the NHS of a company cofounded by the tech billionaire Peter Thiel, who said in 2023: “The NHS makes people sick
- It said NHS trusts, including Chelsea and Westminster, Leicester, Northampton, Bath, North Cumbria, Croydon, Great Western, Dorset, Chesterfield, Ashford and St Peters and Norfolk have publicly
Summary
Some health bodies said the £330m federated data platform (FDP) operated by the controversial US company had made it easier to manage waiting lists and has improved surgery scheduling. The responses come as Andy Burnham’s government faces a crunch decision about whether to exercise a break clause in the seven-year NHS-Palantir deal, which was intended to better integrate the health system’s data to improve clinical accuracy and efficiency. According to more than two dozen FOI responses reviewed by the Guardian, 16 trusts and health boards declared they do not use it, following its introduction in March 2024. Cambridgeshire and Peterborough NHS foundation trust said it has used the system but it has “not offered significant improvements on local systems”.